New diabetes clinical trial: Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France

Published on: May 31, 2023 at 11:00AM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Sodium/glucose cotransporter-2 inhibitors (SGLT2i)
Sponsor:   Boehringer Ingelheim
Not yet recruiting
https://ift.tt/PbhKIxt